This Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug
This Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug
This Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance.